1. Home
  2. TRDA vs MXF Comparison

TRDA vs MXF Comparison

Compare TRDA & MXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$4.65

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Logo Mexico Fund Inc. (The)

MXF

Mexico Fund Inc. (The)

N/A

Current Price

$19.88

Market Cap

295.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TRDA
MXF
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
295.5M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
TRDA
MXF
Price
$4.65
$19.88
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
★ $17.75
N/A
AVG Volume (30 Days)
★ 449.9K
41.7K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $25,421,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$361.69
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.11
$18.62
52 Week High
$16.45
$23.00

Technical Indicators

Market Signals
Indicator
TRDA
MXF
Relative Strength Index (RSI) 44.20 37.81
Support Level $4.18 $19.65
Resistance Level $5.13 $22.26
Average True Range (ATR) 0.51 0.42
MACD 0.05 -0.05
Stochastic Oscillator 23.15 0.00

Price Performance

Historical Comparison
TRDA
MXF

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About MXF Mexico Fund Inc. (The)

Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

Share on Social Networks: